Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ICUCW
SEASTAR MEDICAL HOLDING CORPORATION
NASDAQ
$0.02
▼ DOWN 6.82% (-0.00)

KEY STATISTICS

Market Cap$634.43 K
52w High$0.04
52w Low$0.02
Dividend Yield—
Frequency—
P/E-0.01
Volume2.33K
Shares Out.36.05M

COMPANY

LEADERSHIP

Eric Schlorff
CHIEF EXECUTIVE
Eric Schlorff

COMPENSATION 2026

Salary$420,000
Stock Awards$97,863
Incentive Plan Pay$0
All Other Comp.$0
Total$637,960

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 18, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
17

UPCOMING EARNINGS

DateNov 18, 2026
DayWednesday
Rev. Est.$500.00K
NOV
18
WED

PRICE

$0.02 ▼ DOWN 6.82% (−$0.00)
$0.01$0.02$0.02$0.02$0.0211:09 AM11:31 AM11:54 AM12:16 PM12:39 PM1:01 PM1:24 PM0.02

About SeaStar Medical Holding Corporation

https://www.seastarmedical.com ↗

SeaStar Medical develops extracorporeal therapies to treat hyperinflammation and cytokine storm in critically ill patients across conditions like kidney injury, heart failure, and hepatorenal syndrome.

INDUSTRY

Biotechnology

A PRODUCT SEASTAR MEDICAL HOLDING CORPORATION IS KNOWN FOR

QUELIMMUNE (SCD-PED)
QUELIMMUNE (SCD-PED)

QUELIMMUNE, SeaStar Medical’s FDA-approved therapy launched in 2024, uses SCD technology to treat pediatric patients with life-threatening AKI from sepsis by reducing hyperinflammation.

COMPETITORS

COMPETITOR
AEMD COMPARE
BAX COMPARE
CTSO COMPARE
FMS COMPARE
NUWE COMPARE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
4.58%
HOLDERS
20
TOP 12 OF 20 · RANKED BY POSITION SIZE
Ayrton Capital LLC
250.0K sh · $3.52K
Atw Spac Management LLC
245.2K sh · $6.64K
Boothbay Fund Management, LLC
245.2K sh · $58.85K
Linden Advisors LP
218.1K sh · $5.95K
Goldman Sachs Group Inc
211.4K sh · $6.09K
Lmr Partners Llp
125.0K sh · $3.6K
Equitec Proprietary Markets, LLC
80.4K sh · $1.6K
Susquehanna International Group, Llp
74.7K sh · $859
Skyview Investment Advisors, LLC
64.7K sh · $1K
Clear Street Group Inc.
46.8K sh · $1.27K
Clear Street LLC
46.7K sh · $929
Virtu Financial LLC
42.0K sh · $1K

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book5
Overall Score3

INSIDER TRADES

★
OFFICER: CHIEF FINANCIAL OFFICER
Messinger Michael
Purchase · 750 shares
2026-08-18
★
OFFICER: CHIEF EXECUTIVE OFFICER
Schlorff Eric
Purchase · 10.3K shares
2026-07-01
★
OFFICER: CHIEF MEDICAL OFFICER
Chung Kevin
Purchase · 7.2K shares
2026-07-01
★
DIRECTOR
Vincent Bernadette N
Purchase · 4.0K shares
2026-07-01

SECTORS PEERS

PEERPRICE
LGVN$6.74COMPARE
DARE$0.76COMPARE
ADTX$0.01COMPARE
CTXR$0.58COMPARE
PULM$1.50COMPARE
MBRX$0.66COMPARE
FBLG$1.55COMPARE
ASBP$8.75COMPARE